China, Indonesia achieve fruitful results in bilateral cooperation

STORY: China, Indonesia achieve fruitful results in bilateral cooperation DATELINE: Nov. 14, 2022 LENGTH: 00:03:32 LOCATION: Jakarta CATEGORY: POLITICS/ECONOMY SHOTLIST: 1. various of projects 2. various of Jakarta-Bandung High-Speed Railway 3. SOUNDBITE 1 (Chinese): FAN SHAOJIE, Jakarta-Bandung HSR project department, China Railway Electrification Engineering Group 4. various of Indonesia Morowali Industrial Park (IMIP) 5. various of Indonesia Weda Bay Industrial Park (IWIP) 6. SOUNDBITE 2 (Chinese): ZHANG FAN, Head of IMIP 7. SOUNDBITE 3 (Chinese): HE XIAOZHEN, Head of IWIP 8. various of China's mRNA COVID-19 vaccine 9. SOUNDBITE 4 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 10. SOUNDBITE 5 (Chinese): YING BO, Founder of AbogenBio STORYLINE: China and Indonesia are both major developing countries and emerging economies. The two sides have extensive converging interests and broad space for cooperation. In recent years, the cooperation between the two countries has achieved fruitful resu

Indonesia approves emergency use of China's mRNA COVID-19 vaccine

STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog